Anti-CNTN1 antibodies have a well-established role in CIDP, as evidenced by their disruption of axo-glial contacts at the paranodes; however, their function in MN is still unknown. Here, CNTN1 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.